Browsing Tag
Evaxion A/S
2 posts
What clinicians may watch next in Evaxion A/S’s artificial intelligence vaccine platform
What clinicians and investors may watch next in Evaxion A/S’s AI vaccine platform as polio and CMV programs test the commercial case for TechBio innovation.
Evaxion reports promising immune-biomarker results for AI-designed EVX-01 vaccine with KEYTRUDA
Discover how Evaxion’s AI-powered EVX-01 vaccine drives potent T-cell responses and strengthens its melanoma phase 2 program with KEYTRUDA.